MAPT and Alzheimer disease: Prevention of MAPK overactivation can reduce Aβ deposition, tau hyperphosphorylation,25 neuronal apoptosis,26 and memory impairment.27 MAPKs could be potential targets for novel and effective therapeutics of AD.